Skip to content

A clinical study to find out the effect of combination tablet,ofloxacin and ornidazole in severe gum diseased patients

Evaluation of ofloxacin and ornidazole as an adjunct to scaling and root planing in the treatment of generalized chronic periodontitis-A randomized clinical study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031487
Enrollment
40
Registered
2021-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ofloxacin 500 mg BD for 5days Ornidazole 200mg BD for 5days: After Scaling and Root planing Control Intervention1: NIL: NIL

Sponsors

Sri Hasanamba Dental College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willingness to comply with the study protocol Subjects who were diagnosed with chronic generalized periodontitis Systemically healty individuals between the age group of 25-55 range Subjects who were diagnosed with periodontal pocket depth >5mm

Exclusion criteria

Exclusion criteria: Subjects suffering from any known systemic diseases Subjects who are smokers Pregnant and lactating females subjects who had received any periodontal therapy or antibiotic therapy in the last 6 months Unable or not willing to comply with study protocol Subjects with history of any drug allergy

Design outcomes

Primary

MeasureTime frame
1.Gingival index(Loe and Silness 1963) 2.papillary bleeding index(Muhlemann 1977) 3.Probing pocket depthTimepoint: 1.Gingival index(Loe and Silness 1963) 2.papillary bleeding index(Muhlemann 1977) 3.Probing pocket depth

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Shivaprasad D

Sri Hasanamba Dental College and Hospital

dr.shivprasadd@gmail.com9986248822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026